Anna Oughton, Pharm. D.
Senior Director, Clinical Development - Ophthalmology
Anna Oughton is the Senior Director, Clinical Development - Ophthalmology at Exegenesis Bio, with over 16 years of clinical research experience.
Before joining Exegenesis Bio, Anna has been performing drug development in Industry for over 16 years for both pharmaceutical and biotechnology companies such as GSK as the Clinical Development Manager, Kanghong Pharma as the manager, Senior Manager, Associate Director for Clinical Research and Development, HuiGene Therapeutics as the Senior Director, Global Clinical Development and Janssen Pharmaceuticals, Apple and 23&Me for consulting projects. She also performed 7 years at Fox Chase Cancer Center as a Clinical Pharmacist. She has been focused for the last 6 years on ophthalmology but has worked in other indications, including cardiovascular, oncology, rare disease, neurology, respiratory and musculoskeletal disorders in Phases I through III globally.
Anna has a Doctor of Pharmacy degree from Philadelphia College of Pharmacy and is currently working on completing the Executive MBA program in February 2024.